Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy

Pflugers Arch. 2022 Jan;474(1):33-61. doi: 10.1007/s00424-021-02650-y. Epub 2022 Jan 3.

Abstract

Diabetic cardiomyopathy is defined as the myocardial dysfunction that suffers patients with diabetes mellitus (DM) in the absence of hypertension and structural heart diseases such as valvular or coronary artery dysfunctions. Since the impact of DM on cardiac function is rather silent and slow, early stages of diabetic cardiomyopathy, known as prediabetes, are poorly recognized, and, on many occasions, cardiac illness is diagnosed only after a severe degree of dysfunction was reached. Therefore, exploration and recognition of the initial pathophysiological mechanisms that lead to cardiac dysfunction in diabetic cardiomyopathy are of vital importance for an on-time diagnosis and treatment of the malady. Among the complex and intricate mechanisms involved in diabetic cardiomyopathy, Ca2+ mishandling and mitochondrial dysfunction have been described as pivotal early processes. In the present review, we will focus on these two processes and the molecular pathway that relates these two alterations to the earlier stages and the development of diabetic cardiomyopathy.

Keywords: Calcium mishandling; Diabetic cardiomyopathy; Mitochondrial dysfunction.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cytosol / metabolism
  • Diabetic Cardiomyopathies / etiology*
  • Diabetic Cardiomyopathies / metabolism
  • Excitation Contraction Coupling
  • Humans
  • Mitochondria, Heart / metabolism*
  • Prediabetic State / metabolism*
  • Sarcoplasmic Reticulum / metabolism*

Substances

  • Calcium